Jefferies Group's IMDX Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 18,100 shares of Insight Molecular Diagnostics Inc. (IMDX) worth $106,790, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in IMDX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Insight Molecular Diagnostics (IMDX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Insight Molecular Diagnostics (IMDX) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +18,100 | New Buy | 18,100 | $5.90 |
Jefferies Group's Insight Molecular Diagnostics Investment FAQs
Jefferies Group first purchased Insight Molecular Diagnostics Inc. (IMDX) in Q2 2026, acquiring 18,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Insight Molecular Diagnostics Inc. (IMDX) for 1 quarters since Q2 2026.
Jefferies Group's largest addition to Insight Molecular Diagnostics Inc. (IMDX) was in Q2 2026, adding 18,100 shares worth $106,790.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 18,100 shares of Insight Molecular Diagnostics Inc. (IMDX), valued at approximately $106,790.
As of the Q2 2026 filing, Insight Molecular Diagnostics Inc. (IMDX) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Insight Molecular Diagnostics Inc. (IMDX) was 18,100 shares, as reported at the end of Q2 2026.